Navigation Links
Cardium Reports Excellagen Matrix Clinical Study Results Accepted for Publication by Peer-Reviewed Journal, and Updates Product Plans
Date:12/28/2010

SAN DIEGO, Dec. 28, 2010 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported that data from the Company's Matrix Phase 2b clinical study has been accepted for publication in the journal, Wound Repair and Regeneration and provided an update on plans for commercialization of its Excellagen formulated collagen topical wound dressing.  

(Logo:  http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO)

The clinical paper now accepted for publication is titled, "Formulated Collagen Gel Accelerates Healing Rate Immediately after Application in Patients with Diabetic Neuropathic Foot Ulcers", and was authored by nine investigators who participated in the Matrix study and Cardium researchers and is expected to be published in early 2011.  Excellagen formulated collagen topical gel wound care dressing was studied in a controlled, double blind Matrix Phase 2b clinical study of chronic diabetic lower extremity ulcers.  Wounds treated with the Excellagen formulated collagen (2.6%) topical gel showed a statistically significant acceleration of wound healing during the first week following a one-time application compared to patients receiving standard of care therapy, a response that was sustained over a 14 day period.  The authors suggest that more frequent applications of Cardium's Excellagen product candidate hold promise to significantly improve overall incidence of complete wound closure.

The Company also provided an update with respect to planned commercialization of its Excellagen topical gel wound care dressing, which comprises a specially formulated collagen matrix gel being produced under a supply agreement with Devro Medical Limited, part of Devro PLC, a public limited company registered in Scotland.  Certain changes to the manufacturing process fo
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Cardium Reports on Third Quarter 2010 Financial Results and Recent Developments
2. Cardium to Present at the LifeTech Capital Miami Medical Investors Conference
3. Cardium Gains Exclusive Access to Novel Polymer-Based Nitric Oxide Technology for Expansion of Wound Healing Product Portfolio
4. Cardium to Present at 10th Annual Biotech in Europe Investor Forum
5. Cardium Regains Listing Compliance With NYSE Amex
6. Cardium to Present at MDB Capital Groups 2010 Bright Lights Conference
7. Cardiums Exchange Listing Compliance Plan Accepted by NYSE AMEX
8. Cardium Reports on Third Quarter 2009 Financial Results and Recent Developments
9. Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds
10. Cardium Completes $6.0 Million Registered Direct Offering
11. Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Dec. 22, 2014  ( www.competitivehealth.com ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
(Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one ... of Nick Maroulis, Pharm.D. to the newly created position ... In this position, Dr. Maroulis will continue to manage ... of our multi-site pharmacies as the company expands. Dr. ... that time he has served in many different capacities ...
(Date:12/19/2014)... Dec. 19, 2014 Bina Technologies, Inc. (Bina, ... that they have been acquired by Roche (SIX: RO, ... privately held company that provides a big data platform ... (NGS) data for the academic and translational research markets. ... and will continue to focus on development of their ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... , , SUNRISE, Fla., July 28 ... delivering intelligent devices and biologics that help monitor, diagnose and treat ... cleared a phase I clinical trial for MyoCell SDF-1 (Stromal Derived ... trial will enroll 15 patients in a multicenter, randomized, dose escalation ...
... , , , ... CYNO ), a leading developer and manufacturer of a broad array of ... June 30, 2009. , , Second Quarter 2009 Financial ... June 30, 2009 were $20.8 million, compared with $39.2 million in the same ...
... BIRMINGHAM, Ala., July 28 BioCryst Pharmaceuticals (Nasdaq: ... financial results will be released on Thursday, July 30, 2009. ... at 11:00 a.m. Eastern Time to discuss the financial results ... call will be led by Jon P. Stonehouse, President and ...
Cached Biology Technology:United States FDA Clears the REGEN Trial to Test Bioheart's Combination Gene and Stem Cell Therapy in Heart Failure Patients 2United States FDA Clears the REGEN Trial to Test Bioheart's Combination Gene and Stem Cell Therapy in Heart Failure Patients 3United States FDA Clears the REGEN Trial to Test Bioheart's Combination Gene and Stem Cell Therapy in Heart Failure Patients 4Cynosure Reports Second Quarter 2009 Financial Results 2Cynosure Reports Second Quarter 2009 Financial Results 3Cynosure Reports Second Quarter 2009 Financial Results 4Cynosure Reports Second Quarter 2009 Financial Results 5Cynosure Reports Second Quarter 2009 Financial Results 6Cynosure Reports Second Quarter 2009 Financial Results 7Cynosure Reports Second Quarter 2009 Financial Results 8Cynosure Reports Second Quarter 2009 Financial Results 9Cynosure Reports Second Quarter 2009 Financial Results 10Cynosure Reports Second Quarter 2009 Financial Results 11Cynosure Reports Second Quarter 2009 Financial Results 12Cynosure Reports Second Quarter 2009 Financial Results 13BioCryst Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009 2
(Date:12/19/2014)... , Dec. 18, 2014 Research and ... the addition of the "iPhone 5S Fingerprint ... Report" report to their offering. ... the acquisition of AuthenTec in July 2012, Apple ... 5S. It is currently the only device of ...
(Date:12/17/2014)... Dec. 15, 2014 The Defense Logistics ... easier to detect and prevent counterfeit microcircuits from ... the agency started performing an in-house microcircuit anti-counterfeit ... the authenticity of purchased microcircuits while increasing their ... control measures will be conducted at DLA,s Electronics ...
(Date:12/15/2014)... Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ... "Global Facial Recognition Market 2015-2019" report to ... Facial recognition is a technology ... system measures the overall facial feature of a ... the distance between eyes. Facial recognition is used ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... Conn.Paleontologists have discovered that a group of remarkable ancient ... much larger sizes than previously thought, thanks to extraordinarily ... as anomalocaridids, were already thought to be the largest ... Explosion" that saw the sudden appearance of all the ...
... Whale sharks ( Rhincodon typus ) are often thought to ... ocean. Scientists at the Smithsonian Institution and colleagues, however, have ... whale sharks can be gregarious and amass in the hundreds ... whale sharks have been witnessed in the past, ranging from ...
... board feet of softwood logs and 224.9 million board feet ... and Alaska in January, February, and March of this year, ... Station. "The volume of softwood log exports was up ... quarter of 2010, while the volume of softwood lumber exports ...
Cached Biology News:Scientists discover fossil of giant ancient sea predator 2Scientists discover the largest assembly of whale sharks ever recorded 2West coast's log, lumber exports increase in first quarter of 2011 2West coast's log, lumber exports increase in first quarter of 2011 3
... PCR carry-over contamination, which prevents false ... products from previous PCR amplifications without ... improves amplification ,Optimized for use with ... instrument systems , The GeneAmp PCR ...
... that catalyzes the hydrolysis of,starch to ... dextrins. The,level of a-amylase in various ... of,clinical significance in the diagnosis of ... and microbial a-amylases are,important enzymes for ...
... Labsystems Wellmix is a high-quality four-place microplate ... The shaking speed is adjustable from 100 ... speed and a small orbit ensure effective ... time is quick and easy to set ...
Rabbit polyclonal to STUB1 ( Abpromise for all tested applications). entrezGeneID: 10273 SwissProtID: Q9UNE7...
Biology Products: